Evidence for tight coupling of receptor occupancy by thyrotropin-releasing hormone to phospholipase C-mediated phosphoinositide hydrolysis in rat pituitary cells: use of chlordiazepoxide as a competitive antagonist
- PMID: 3015558
- DOI: 10.1210/endo-119-2-833
Evidence for tight coupling of receptor occupancy by thyrotropin-releasing hormone to phospholipase C-mediated phosphoinositide hydrolysis in rat pituitary cells: use of chlordiazepoxide as a competitive antagonist
Abstract
Chlordiazepoxide (CDE) has been shown to antagonize the effects of TRH to stimulate the hydrolysis of phosphoinositides and elevate cytoplasmic free calcium in rat pituitary tumor (GH3) cells. Herein, we show that CDE inhibits TRH stimulation of PRL secretion and that the effect of CDE to antagonize TRH action is caused by its ability to compete with TRH for binding to receptors on GH3 cells. We also use CDE to explore whether continued receptor occupancy is required for prolonged stimulation of cellular responses. CDE had no effect on basal PRL secretion, but caused a dose-dependent inhibition of TRH-induced PRL secretion. CDE decreased the affinity of TRH binding to intact GH3 cells without affecting the maximum binding capacity. As shown previously, CDE had no effect on phosphoinositide metabolism, which was monitored because it appears to be a mechanism for signal transduction by TRH, and when added simultaneously with TRH, caused a dose-dependent inhibition of TRH-induced phosphoinositide metabolism. When CDE was added to cells 2.5 or 5 min after TRH, CDE rapidly terminated the stimulation by TRH of phosphoinositide hydrolysis, shown as inhibition of the continued formation of inositol phosphates and inositol, and of the decrease in phosphoinositides. Lastly, when cells were stimulated with 50 nM TRH, then exposed to 100 microM CDE, and finally to 1000 nM TRH, inositol phosphate formation was stimulated, then inhibited, and then restimulated. These data demonstrate that CDE acts as a competitive antagonist of TRH action on GH3 cells by competing with TRH for binding to its receptor and that continued stimulation by TRH of phospholipase C-mediated hydrolysis of phosphoinositides is tightly coupled to receptor occupancy.
Similar articles
-
A constitutively active mutant thyrotropin-releasing hormone receptor is chronically down-regulated in pituitary cells: evidence using chlordiazepoxide as a negative antagonist.Mol Endocrinol. 1995 Nov;9(11):1455-60. doi: 10.1210/mend.9.11.8584022. Mol Endocrinol. 1995. PMID: 8584022
-
Effects of thyrotropin-releasing hormone on phosphoinositides and cytoplasmic free calcium in thyrotropic pituitary cells.Endocrinology. 1986 Jan;118(1):163-9. doi: 10.1210/endo-118-1-163. Endocrinology. 1986. PMID: 3000732
-
Thyrotropin-releasing hormone receptor occupancy determines the fraction of the responsive pool of inositol lipids hydrolysed in rat pituitary tumour cells.Biochem J. 1990 Oct 15;271(2):331-6. doi: 10.1042/bj2710331. Biochem J. 1990. PMID: 2173558 Free PMC article.
-
Role of thyrotropin-releasing hormone in prolactin-producing cell models.Neuropeptides. 2015 Dec;54:73-7. doi: 10.1016/j.npep.2015.08.001. Epub 2015 Aug 5. Neuropeptides. 2015. PMID: 26297348 Review.
-
Use of receptor antagonist in elucidating the mechanism of action of TRH in GH3 cells.Ann N Y Acad Sci. 1989;553:197-204. doi: 10.1111/j.1749-6632.1989.tb46642.x. Ann N Y Acad Sci. 1989. PMID: 2566295 Review. No abstract available.
Cited by
-
The interaction of benzodiazepines with thyrotropin-releasing hormone receptors on clonal pituitary cells.Br J Pharmacol. 1989 Feb;96(2):450-6. doi: 10.1111/j.1476-5381.1989.tb11837.x. Br J Pharmacol. 1989. PMID: 2538195 Free PMC article.
-
Expression cloning of a cDNA encoding the mouse pituitary thyrotropin-releasing hormone receptor.Proc Natl Acad Sci U S A. 1990 Dec;87(24):9514-8. doi: 10.1073/pnas.87.24.9514. Proc Natl Acad Sci U S A. 1990. PMID: 2175902 Free PMC article.
-
Inverse agonist abolishes desensitization of a constitutively active mutant of thyrotropin-releasing hormone receptor: role of cellular calcium and protein kinase C.Br J Pharmacol. 1999 Mar;126(5):1097-106. doi: 10.1038/sj.bjp.0702415. Br J Pharmacol. 1999. PMID: 10204996 Free PMC article.
-
Characteristics and modulation by thyrotropin-releasing hormone of an inwardly rectifying K+ current in patch-perforated GH3 anterior pituitary cells.Pflugers Arch. 1992 Oct;422(1):31-9. doi: 10.1007/BF00381510. Pflugers Arch. 1992. PMID: 1331977
-
Synthesis and characterization of a high-affinity photoactivatable analogue of thyrotropin-releasing hormone.Biochem J. 1992 Jan 1;281 ( Pt 1)(Pt 1):179-84. doi: 10.1042/bj2810179. Biochem J. 1992. PMID: 1310004 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials